- FOUNDED 2012
Overview
COSA members formed the cancer survivorship group in November 2012 in recognition of the growing importance of survivorship care of people diagnosed with cancer. Our multidisciplinary Group provides a platform for the discussion and ongoing development of survivorship care in Australia. We recognise that quality survivorship care is essential to supporting the well-being of people diagnosed with cancer and their families.
The overarching aim of the COSA Survivorship Group is to advance care and research to improve outcomes for all Australians after cancer treatment.
Group information
Survivorship Group objectives include:
- Represent the needs of the broad range of health professionals involved in delivering care for cancer survivors
- Provide a forum for education, discussion and exchange of information between health professionals involved in cancer survivorship care
- Foster research in cancer survivorship
- Promote and advocate for improved survivorship services and access to care for all Australians living with and beyond cancer
- Engage stakeholders in the area of cancer survivorship care to ensure a coordinated, national approach to survivorship care in Australia and to facilitate policy development to inform such care
Working Groups
Advocacy
- Financial Toxicity Roadmap to Reducing Financial Toxicity Experienced by People Affected by Cancer – March 2024
- PROActive workshop advocacy priority areas – July 2024
- Survivorship Policy Working Group submission to the draft Australian Cancer Plan consultation - December 2022
- Financial Toxicity in Cancer Care – May 2022
- Survivorship Primary Care Working Group submission to Australian Cancer Plan – March 2022
- Survivorship Policy Working Group submission to Australian Cancer Plan – March 2022
COSA Model of Care
The COSA Model of Survivorship Care is under review. Any members who want to contribute to the update should contact [email protected]
- Clinical Oncology Society of Australia position statement on cancer survivorship care – AJGP 2019
- COSA Model of Survivorship Care – January 2016
Current Fellows
Previous Fellowships:
The 2025 National Cancer Survivorship Conference will be held in Melbourne from the 6-7 March 2025.
Collaborative Survivorship Webinars are available to all members
Catch up on COSA Survivorship Group eNews from the last few years. The Survivorship Group eNews is only available for members, so you'll need to login to access.
COSA Survivorship Group on X (formally Twitter)
Follow and tag @COSA_Surviv
Community Guidelines
Group Executive Committee
Chair: A/Prof Nicolas Hart, University of Technology Sydney, NSW
Deputy Chair: Dr Kate Webber, Monash Health / Monash University, VIC
Prof Gail Garvey, The University of Queensland, QLD
Dr Mahesh Iddawela, Alfred Health & La Trobe Regional Hospital, VIC
Dr Carolyn Mazariego, University of New South Wales/SPHERE, NSW
Ms Rebecca McIntosh, healthAbility / Peter MacCallum Cancer Centre, VIC
Ms Carmel O’Kane, Wimmera Cancer Centre / Grampians Health Horsham, VIC
A/Professor Anna Ugalde, Deakin University VIC
Dr Thomas Walwyn, Perth Children's Hospital, WA
Co-opted Executive members
Chair, PRO Working Group: Prof Bogda Koczwara AM, Flinders Centre for Innovation in Cancer, SA
eNews Co-editor: Dr Md Mijanur Rahman, The Daffodil Centre, NSW
eNews Co-editor: Dr Carla Thamm, Flinders University SA/Metro South Hospital and Health Service QLD
Primary care advisor: Dr Sean Black-Tiong, Lift Cancer Care Services, SA
Dr Elysia Thornton-Benko, General Practice, University of New South Wales, NSW
Co-Chair, Financial Toxicity Working Group: Megan Varlow, Cancer Council Australia
Terms of Reference - Council approved 6 August 2021, updated May 2024
You can view all COSA Quickfires on our YouTube channel
What’s the latest
Group Chair
Group Chair
Nicolas Hart
Survivorship Group Chair
Join Australia's leading oncology community & make an impact
Become a COSA memberTwitter
@COSAoncology
Follow
COSAoncology 12 days ago
RT @oncodaily: Disability and cancer care – We can do both! - @ShonaEdwards2 @CVSAinfo @COSAoncology https://t.co/baqGDwRe8W #Cancer #Ca…
Read More >COSAoncology 12 days ago
RT @AYAGlobalCancer: Great to see how research has expanded in #AYA psychosocial care 🙌🏻 Dr Ursula Sansom-Daly @usansomdaly presents the up…
Read More >COSAoncology 24 days ago
Read the latest news from COSA and COSA members in our November eNewsletter. Check your inbox or login to your COSA member account to view now: https://t.co/5ib5Nlou8I https://t.co/ApABAA7WHN
Read More >COSAoncology 26 days ago
Congratulations David Thomas for recognition of your leadership and groundbreaking work in genomics in cancer care. And congratulations to all the recipients of the 2024 Premier's Awards for Outstanding Cancer Research. #cancerNSWawards
Read More >COSAoncology 26 days ago
Congratulations Ashfaq Chauhan for recognition of your work to enhance cancer care for people from CALD backgrounds.
Read More >COSAoncology 26 days ago
Congratulations @DrNicolasHart for recognition of your work to improve outcomes of all people affected by cancer.
Read More >COSAoncology 26 days ago
Congratulations @yapml for recognition of your important work in equity and cancer care.
Read More >COSAoncology one month ago
You have till this Friday 22 Nov '24 to submit an abstract for the National Cancer Survivorship Conference #Surv25 in Melbourne, 6-7 March. We particularly welcome submissions from survivors themselves and those whose work is in partnership with survivors https://t.co/6V4F3x1vvF https://t.co/vjp4hfcVXN
Read More >COSAoncology one month ago
You have till this Friday 22 Nov '24 to submit an abstract for the National Cancer Survivorship Conference #Surv25 to be held in Melbourne, March 2025. We particularly welcome submissions from survivors and those whose work is in partnership with survivors https://t.co/6V4F3x1vvF https://t.co/87PUAMTxwA
Read More >COSAoncology one month ago
It's a wrap! Thanks to everyone who made #COSA24 a huge success, not least the almost 900 delegates who joined us on the Gold Coast. Watch the video for all the stats. https://t.co/ysZNul66qH
Read More >